生検針市場：製品タイプ、用途、手技、エンドユーザー、地域別、2026年～2032年

生検針市場の評価、2026年～2032年

生検針市場は、がんの有病率の上昇と早期発見に対する意識の高まりにより急速に拡大しています。これらの針は診断検査用の組織サンプルを採取するために必要です。生検技術の技術的進歩、高齢化人口の増加、政府のがん啓発イニシアチブの増加が主要な市場促進要因の一つです。これにより、市場規模は2024年に103億6,000万米ドルを突破し、2032年には178億3,000万米ドルに達する見込みです。

北米は、高度なヘルスケア・インフラと高いがん罹患率により、最大の市場シェアを占めています。同市場の主要企業には、ベクトン・ディッキンソン社、ホロジック社、アルゴン・メディカル・デバイス社などがあります。低侵襲手術の需要が高まるにつれて、この業界は上昇を続ける可能性が高いです。生検針に対する需要の高まりは、2026年から2032年までのCAGR 7.02%での市場の成長を可能にしています。

生検針市場定義/概要

生検針は、診断目的で体内から組織サンプルを採取する専門医療器具です。生検針には、芯針、細針、真空アシスト針などさまざまなスタイルがあり、それぞれ特定の組織タイプや診断の必要性、特にがんの発見に適しています。

生検針は、診断検査用の組織サンプルを採取するために使用され、がんを含む疾患の診断と分析に役立ちます。生検針は、身体の様々な部位から細胞を採取するための低侵襲な方法を提供し、それによって診断や治療計画のための重要な情報を提供します。

生検針は、低侵襲技術が進化し、がん診断が向上し、病気の早期発見に対する意識が高まるにつれて、今後さらに使用される可能性が高いです。精度の向上や患者の不快感の軽減といった針技術の向上は、医療現場での使用を加速させると思われます。

高齢化人口の増加は生検針市場の成長を促進するか？

高齢化の進展は生検針市場を大きく押し上げると予想されます。米国国勢調査局によると、2030年までにベビーブーム世代がすべて65歳以上になり、高齢者の総数は730億人に達します。この層は針生検のような診断処置を必要とする可能性が高いです。

米国国立がん研究所によると、男女の約39.5％が生涯のある時点でがんと診断され、診断年齢の中央値は66歳です。CDCは、2018年に新たに発生したがん症例を1,708,921例報告し、がんは65歳以上の死因の第2位となっています。2050年までに、65歳以上のアメリカ人の数は885億人に達すると予測されており、生検針の必要性はさらに高まる。

生検手術の高コストは生検針市場の妨げになるか？

生検手術費用の高さが生検針市場の成長を制限する可能性があります。高度な画像診断技術や特殊な針などの生検治療にかかる費用は、特に医療財政の乏しい地域では、個人やヘルスケアシステムによっては高すぎるかもしれないです。

さらに、特に保険が完全に適用されない場合、高額な費用が患者の診断治療への意欲を削ぐ可能性があります。このような価格の障壁は、重要な診断検査へのアクセスを制限し、診断や治療の遅れにつながる可能性があります。技術開発とがんなどの疾病の蔓延が生検針の需要を高める一方で、市場開拓は治療費によって制限される可能性があります。価格引き下げとヘルスケア・アクセス強化の取り組みは、こうした問題を緩和し市場を拡大するのに役立つ可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 生検針市場：製品タイプ別

• 生検針
• 吸引針

第5章 生検針市場：用途別

• 腫瘍/がん用途
• 創傷用途

第6章 生検針市場：手技別

• 画像ガイド下手技
• 非画像ガイド下手技

生検針市場：エンドユーザー別

• 病院および外科センター
• 診断クリニックおよび病理研究所
• 外来医療センター
• 研究・学術機関

第7章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Becton
• Medtronic plc
• Boston Scientific Corporation
• FUJIFILM Holdings Corporation
• Dickinson & Company（BD）
• Becton
• Cardinal Health
• Hologic, Inc.
• Olympus Corporation
• Argon Medical Devices, Inc.
• Devicor Medical Products, Inc.
• Braun Melsungen AG
• Cook Group Incorporated

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Biopsy Needles Market Valuation - 2026-2032

The Biopsy Needles Market is expanding rapidly due to the rising prevalence of cancer and increasing awareness of early detection. These needles are required for collecting tissue samples for diagnostic testing. Technological advancements in biopsy techniques, a growing aging population and increasing government cancer awareness initiatives are among the key market drivers. This is likely to enable the market size surpass USD 10.36 Billion valued in 2024 to reach a valuation of around USD 17.83 Billion by 2032.

North America possesses the largest market share due to advanced healthcare infrastructure and high cancer incidence rates. Key players in the market include companies like Becton, Dickinson and Company, Hologic, Inc. and Argon Medical Devices. The industry is likely to continue rising as demand for minimally invasive procedures increases. The rising demand for Biopsy Needles is enabling the market grow at a CAGR of 7.02% from 2026 to 2032.

Biopsy Needles Market: Definition/ Overview

Biopsy needles are specialist medical devices that collect tissue samples from the body for diagnostic purposes. They come in a variety of styles, including core, fine and vacuum-assisted needles, each suited for a specific tissue type and diagnostic necessity, particularly in cancer detection.

Biopsy needles are used to collect tissue samples for diagnostic testing, which aids in the diagnosis and analysis of diseases, including cancer. They provide a minimally invasive way for collecting cells from diverse bodily areas, thereby providing critical information for diagnosis and treatment planning.

Biopsy needles will most likely be used more in the future as minimally invasive techniques evolve, cancer diagnoses improve and awareness of early illness detection grows. Improved needle technologies, such as increasing precision and less patient discomfort, will accelerate their use in medical practices.

Will Growing Aging Population to Boost the Biopsy Needles Market Growth?

The growing aging population is expected to significantly boost the biopsy needle market. According to the US Census Bureau, by 2030, all baby boomers will be over the age of 65, bringing the total number of older people to 73 Billion. This demographic is more likely to require diagnostic procedures like needle biopsy.

According to the National Cancer Institute, approximately 39.5% of men and women will be diagnosed with cancer at some point during their lifetimes, with the median age for diagnosis being 66 years. The CDC reported 1,708,921 new cancer cases in 2018, with cancer being the second leading cause of death among those aged 65 and older. By 2050, the number of Americans aged 65 and older is predicted to reach 88.5 Billion, further raising need for biopsy needles.

Will High Cost of Biopsy Operations Hamper the Biopsy Needles Market?

The high cost of biopsy surgeries may limit the growth of the biopsy needles market. The costs of biopsy treatments, such as advanced imaging techniques and specialized needles, might be too expensive for some individuals and healthcare systems, especially in areas with low healthcare financing.

Furthermore, high costs may discourage patients from pursuing diagnostic treatments, particularly in the absence of full insurance coverage. This price barrier can limit access to important diagnostic testing, potentially resulting in delayed diagnosis and treatment. While technical developments and the rising prevalence of diseases such as cancer fuel demand for biopsy needles, the market's expansion may be limited by the cost of treatments. Efforts to cut prices and enhance healthcare access could help to mitigate these issues and expand the market.

Category-Wise Acumens

Will Increasing Need for Early and Accurate Diagnosis Drive the Application Segment?

The growing demand for early and precise diagnosis is a major driver in the biopsy needles application area. Early diagnosis of diseases such as cancer is critical to improve treatment outcomes and survival rates. Biopsy needles are essential for collecting tissue samples for definitive diagnosis, as they aid in determining the presence and stage of illnesses. As healthcare systems prioritize preventive care and precision medicine, the demand for improved diagnostic instruments, such as biopsy needles, increases.

Furthermore, technical advances in biopsy needle design and imaging techniques improve the accuracy and safety of treatments. The rising emphasis on early diagnosis and individualized treatment strategies is projected to drive biopsy needle utilization and market growth.

Will Increasing Demand for Greater Accuracy and Precision in Locating and Sampling Tissues Drive the Procedure Segment?

The growing demand for improved accuracy and precision in locating and sampling tissues is a major driver in the image-guided biopsy procedures market. Image-guided techniques, which use technologies such as ultrasound, CT, or MRI, improve the precision of biopsies by allowing for real-time viewing of target locations. This lowers the likelihood of sampling errors, complications and the need for repeat treatments, ultimately increasing diagnostic accuracy and patient outcomes.

As healthcare professionals and consumers seek more reliable and minimally invasive diagnostic approaches, image-guided biopsies are becoming increasingly popular. This tendency is bolstered by technology advances in imaging and needle design, which make these treatments safer and more efficient. As a result, the demand for image-guided biopsy treatments is likely to rise, boosting the total market for biopsy needles.

Country/Region-wise Acumens

Will High Prevalence of Cancer Drive the Market in North America?

The rising rate of cancer is driving the demand for biopsy needles in North America. With cancer being one of the main causes of mortality in the region, there is a significant emphasis on early identification and correct diagnosis, both of which are critical for effective treatment and improved patient outcomes. North America's well-established healthcare system, combined with extensive access to improved diagnostic tools, makes biopsy needles useful for identifying many malignancies.

Furthermore, a growing understanding of the necessity of regular screenings and early detection contributes to the rising demand for biopsy treatments. Supportive government initiatives and healthcare policies also contribute to industry growth. Consequently, the high cancer prevalence is a crucial element driving the rise of the biopsy needles market in North America.

Will Increasing Healthcare Investments Drive the Market in Asia Pacific Region?

Increasing healthcare investments are a key driver of the Asia-Pacific biopsy needles market. As countries in this region improve their healthcare infrastructure, there is a greater emphasis on strengthening diagnostic skills and increasing access to innovative medical technologies. Governments and business sectors are investing in updating hospitals, clinics and diagnostic centers, increasing the availability of biopsy procedures. This investment also helps healthcare professionals' training in the use of sophisticated diagnostic technologies, which will help to drive market growth.

Furthermore, greater knowledge about early illness detection, combined with an aging population and an increasing prevalence of cancer, drives up demand for biopsy needles. As healthcare systems in Asia-Pacific improve, the market for biopsy needles is likely to rise, driven by these significant investments and the growing emphasis on quality healthcare.

Competitive Landscape

The biopsy needles market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the biopsy needles market include:

Becton

Medtronic plc

Boston Scientific Corporation

FUJIFILM Holdings Corporation

Dickinson & Company (BD)

Becton

Cardinal Health

Hologic, Inc.

Olympus Corporation

Argon Medical Devices, Inc.

Devicor Medical Products, Inc.

Braun Melsungen AG

Cook Group Incorporated

Latest Developments

In November 2022, Cambridge Enterprise released the Cambridge Prostate Biopsy Device (CamPROBE) to minimize infection risk during transrectal biopsies. This unique device includes an integrated needle for localized anesthetic delivery.

In August 2022, Mammotome launched its Mammotome DualCore biopsy system, making its debut in the dual-stage core biopsy equipment market. The device's lightweight, ergonomic and clever design minimizes needle movements and vibrations while improving the entire patient experience.

Biopsy Needles Market, By Category

• Product Type:
• Biopsy Needles
• Aspiration Needles
• Application:
• Tumor/Cancer Applications
• Wound Applications
• Procedure:
• Image-guided Procedures
• Non-image-guided Procedures
• End-User:
• Hospitals & Surgical Centers
• Diagnostic Clinics & Pathology Laboratories
• Ambulatory Care Centers
• Research & Academic Institutes
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Biopsy Needles Market, By Product Type

• Biopsy Needles
• Aspiration Needles

5. Biopsy Needles Market, By Application

• Tumor/Cancer Applications
• Wound Applications

6. Biopsy Needles Market, By Procedure

• Image-guided Procedures
• Non-image-guided Procedures

Biopsy Needles Market, By End-User

• Hospitals & Surgical Centers
• Diagnostic Clinics & Pathology Laboratories
• Ambulatory Care Centers
• Research & Academic Institutes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Becton
• Medtronic plc
• Boston Scientific Corporation
• FUJIFILM Holdings Corporation
• Dickinson & Company (BD)
• Becton
• Cardinal Health
• Hologic, Inc.
• Olympus Corporation
• Argon Medical Devices, Inc.
• Devicor Medical Products, Inc.
• Braun Melsungen AG
• Cook Group Incorporated

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References